In vitro Antimicrobial Activity and the Mechanism of Berberine Against Methicillin-Resistant Staphylococcus aureus Isolated from Bloodstream Infection Patients

References

• Bayer MG, Heinrichs JH, Cheung AL. The molecular architecture of the sar locus inStaphylococcus aureus. J Bacteriol. 1996;178(15):4563–4570.
   PubMed Web of Science ®Google Scholar
• Tan J, Wang J, Yang C, et al. Antimicrobial characteristics of Berberine against prosthetic joint infection-related Staphylococcus aureus of different multi-locus sequence types. BMC Complement Altern Med. 2019;19(1):218. doi:10.1186/s12906-019-2558-9
   PubMed Web of Science ®Google Scholar
• Katatama Y. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44:1549–1555.
   Web of Science ®Google Scholar
• Pinho MG, Filipe SR, de Lencastre H, Tomasz A. Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A inStaphylococcus aureus. J Bacteriol. 2001;183(22):6525–6531.
   PubMed Web of Science ®Google Scholar
• Harkins CP, Pichon B, Doumith M, et al. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol. 2017;18(1). doi:10.1186/s13059-017-1252-9
   Web of Science ®Google Scholar
• Paulsen J, Mehl A, Askim A, Solligard E, Asvold BO, Damas JK. Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: an observational study. BMC Infect Dis. 2015;15:116. doi:10.1186/s12879-015-0849-4
   PubMed Web of Science ®Google Scholar
• Wang L, Yang R, Yuan B, Liu Y, Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm Sin B. 2015;5(4):310–315. doi:10.1016/j.apsb.2015.05.005
   PubMed Web of Science ®Google Scholar
• Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2010;51(Suppl 2):S183–S197. doi:10.1086/653519
   PubMed Web of Science ®Google Scholar
• Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res. 2008;22(8):999–1012. doi:10.1002/ptr.2399
   PubMed Web of Science ®Google Scholar
• Tillhon M, Guaman Ortiz LM, Lombardi P, Scovassi AI. Berberine: new perspectives for old remedies. Biochem Pharmacol. 2012;84(10):1260–1267. doi:10.1016/j.bcp.2012.07.018
   PubMed Web of Science ®Google Scholar
• Slobodnikova L, Kost’alova D, Labudova D, Kotulova D, Kettmann V. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother Res. 2004;18(8):674–676. doi:10.1002/ptr.1517
   Web of Science ®Google Scholar
• Yan D, Jin C, Xiao XH, Dong XP. Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. J Biochem Biophys Methods. 2008;70(6):845–849. doi:10.1016/j.jbbm.2007.07.009
   Google Scholar
• Roser E, Grundemann C, Engels I, Huber R. Antibacterial in vitro effects of preparations from anthroposophical medicine. BMC Complement Altern Med. 2016;16(1):372. doi:10.1186/s12906-016-1350-3
   Web of Science ®Google Scholar
• Xiao CW, Ji QA, Wei Q, Liu Y, Bao GL. Antifungal activity of berberine hydrochloride and palmatine hydrochloride against Microsporum canis -induced dermatitis in rabbits and underlying mechanism. BMC Complement Altern Med. 2015;15:177. doi:10.1186/s12906-015-0680-x
   PubMed Web of Science ®Google Scholar
• Gu S, Song X, Xie R, et al. Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles. Life Sci. 2020;257:118122. doi:10.1016/j.lfs.2020.118122
   PubMed Web of Science ®Google Scholar
• Shen ZQ, Wang J, Tan WF, Huang TM. Berberine inhibits colorectal tumor growth by suppressing SHH secretion. Acta Pharmacol Sin. 2020;42:1190–1194. doi:10.1038/s41401-020-00514-2
   Web of Science ®Google Scholar
• Zhang Y, Gu Y, Ren H, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11(1):5015. doi:10.1038/s41467-020-18414-8
   PubMed Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3(2):163–175. doi:10.1038/nprot.2007.521
   PubMed Web of Science ®Google Scholar
• Isenberg HD. Minimum bactericidal concentration testing. In: Clinical Microbiology Procedures Handbook. Wiley Online Library; 2016:5.14.11.11–15.14.13.16.
   Google Scholar
• Isenberg HD. Synergism testing: broth microdilution checkerboard and broth macrodilution methods. In: Clinical Microbiology Procedures Handbook. Wiley Online Library; 2016:5.16.11–15.16.23.
   Google Scholar
• Wang G, Li L, Wang X, et al. Hypericin enhances beta-lactam antibiotics activity by inhibiting sarA expression in methicillin-resistant Staphylococcus aureus Acta Pharm Sin B. 2019;9(6):1174–1182. doi:10.1016/j.apsb.2019.05.002
   Web of Science ®Google Scholar
• Isenberg HD. Time-kill. In: Clinical Microbiology Procedures Handbook. Wiley Online Library; 2016:5.14.11.11–15.14.13.16.
   Google Scholar
• Xu Y, Shi C, Wu Q, et al. Antimicrobial activity of punicalagin against Staphylococcus aureus and its effect on biofilm formation. Foodborne Pathog Dis. 2017;14(5):282–287. doi:10.1089/fpd.2016.2226
   PubMed Web of Science ®Google Scholar
• Yanfei L, Xiaobin F, Caiping G, et al. Flow cytometry for viability analysis of three bacteria species with fluorescein diacetate vs propidium iodide staining. Acad J Guangzhou Med Univ. 2015;43(02):29–31.
   Google Scholar
• Qian W, Wang W, Zhang J, et al. Antimicrobial and antibiofilm activities of ursolic acid against carbapenem-resistant Klebsiella pneumoniae. J Antibiot. 2020;73(6):382–391. doi:10.1038/s41429-020-0285-6
   PubMed Web of Science ®Google Scholar
• Bozzala JJ. Electron Microscopy Principles and Techniques for Biologists. Jones and Bartlett Publishers; 1999.
   Google Scholar
• Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol. 2008;48:653–683. doi:10.1146/annurev.pharmtox.48.113006.094715
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–292. doi:10.1093/cid/cir034
   PubMed Web of Science ®Google Scholar
• Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment. Crit Care. 2017;21(1):211. doi:10.1186/s13054-017-1801-3
   PubMed Web of Science ®Google Scholar
• Rodvold KA, McConeghy KW. Methicillin-resistant Staphylococcus aureus therapy: past, present, and future. Clin Infect Dis. 2014;58(Suppl 1):S20–S27. doi:10.1093/cid/cit614
   PubMed Web of Science ®Google Scholar
• McGuinness WA, Malachowa N, DeLeo FR. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 2017;90(2):269–281.
   PubMed Web of Science ®Google Scholar
• Gomez Casanova N, Siller Ruiz M, Munoz Bellido JL. Mechanisms of resistance to daptomycin in Staphylococcus aureus. Rev Esp Quimioter. 2017;30(6):391–396.
   Web of Science ®Google Scholar
• Yu HH, Kim KJ, Cha JD, et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food. 2005;8(4):454–461. doi:10.1089/jmf.2005.8.454
   PubMed Web of Science ®Google Scholar
• Zuo GY, Li Y, Han J, Wang GC, Zhang YL, Bian ZQ. Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA). Molecules. 2012;17(9):10322–10330. doi:10.3390/molecules170910322
   PubMed Web of Science ®Google Scholar
• Liu QQ, Han J, Zuo GY, Wang GC, Tang HS. Potentiation activity of multiple antibacterial agents by Salvianolate from the Chinese medicine Danshen against methicillin-resistant Staphylococcus aureus (MRSA). J Pharmacol Sci. 2016;131(1):13–17. doi:10.1016/j.jphs.2015.10.009
   PubMed Web of Science ®Google Scholar
• Wojtyczka RD, Dziedzic A, Kepa M, et al. Berberine enhances the antibacterial activity of selected antibiotics against coagulase-negative Staphylococcus strains in vitro. Molecules. 2014;19(5):6583–6596. doi:10.3390/molecules19056583
   PubMed Web of Science ®Google Scholar
• Aksoy CS, Avci FG, Ugurel OM, Atas B, Sayar NA, Sariyar Akbulut B. Potentiating the activity of berberine for Staphylococcus aureus in a combinatorial treatment with thymol. Microb Pathog. 2020;149:104542. doi:10.1016/j.micpath.2020.104542
   Web of Science ®Google Scholar
• Gao S, Zhang S, Zhang S. Enhanced in vitro antimicrobial activity of amphotericin B with berberine against dual-species biofilms of Candida albicans and Staphylococcus aureus. J Appl Microbiol. 2021;130(4):1154–1172. doi:10.1111/jam.14872
   PubMed Web of Science ®Google Scholar
• Liang RM, Yong XL, Duan YQ, et al. Potent in vitro synergism of fusidic acid (FA) and berberine chloride (BBR) against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). World J Microbiol Biotechnol. 2014;30(11):2861–2869. doi:10.1007/s11274-014-1712-2
   PubMed Web of Science ®Google Scholar
• Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem. 2015;7(4):493–512. doi:10.4155/fmc.15.6
   PubMed Web of Science ®Google Scholar
• Jamal M, Ahmad W, Andleeb S, et al. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018;81(1):7–11. doi:10.1016/j.jcma.2017.07.012
   PubMed Web of Science ®Google Scholar
• Chu M, Zhang MB, Liu YC, et al. Role of berberine in the treatment of methicillin-resistant Staphylococcus aureus infections. Sci Rep. 2016;6:24748. doi:10.1038/srep24748
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun X, Wu J, et al. Berberine damages the cell surface of methicillin-resistant Staphylococcus aureus. Front Microbiol. 2020;11:621. doi:10.3389/fmicb.2020.00621
   Web of Science ®Google Scholar
• Zhang R, Qin X, Kong F, Chen P, Pan G. Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Drug Deliv. 2019;26(1):328–342. doi:10.1080/10717544.2019.1582730
   PubMed Web of Science ®Google Scholar
• Wang D, Yu L, Xiang H, et al. Global transcriptional profiles of Staphylococcus aureus treated with berberine chloride. FEMS Microbiol Lett. 2008;279(2):217–225. doi:10.1111/j.1574-6968.2007.01031.x
   Web of Science ®Google Scholar
• Spizek J, Rezanka T. Lincosamides: chemical structure, biosynthesis, mechanism of action, resistance, and applications. Biochem Pharmacol. 2017;133:20–28. doi:10.1016/j.bcp.2016.12.001
   PubMed Web of Science ®Google Scholar
• Rothstein DM. Alone and in combination. In: Cold Spring Harb Perspect Med. Vol. 6. Rifamycins; 2016:7.
   Google Scholar